Scientific reports、2021年４月号に掲載された”Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation”を紹介します。https://www.nature.com/articles/s41598-021-88118-6
Shokirova, H., Inomata, T., Saitoh, T. et al. Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation. Sci Rep 11, 8647 (2021). https://doi.org/10.1038/s41598-021-88118-6
